| Ticker | AXGN |
|---|---|
| ISIN | US05463X1063 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; ...
Axogen, Inc. opera en el sector Healthcare, industria Medical - Devices.